Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up.

Purpose:To evaluate ocular function and systemic development in premature infants treated with intravitreal bevacizumab injections for retinopathy of prematurity over a period of 5 years.Methods:A prospective, interventional, noncomparative case study. The primary outcome measure was visual acuity.